Retroperitoneal fibrosis – a report of five cases
暂无分享,去创建一个
[1] Priyanka Minocha,et al. Presentation of idiopathic retroperitoneal fibrosis at a young age: A rare case report. , 2016, Intractable & rare diseases research.
[2] M. Prucha,et al. Combination of Steroids and Azathioprine in the Treatment of Ormond's Disease--A Single Centre Retrospective Analysis. , 2016, Prague medical report.
[3] N. Eliakim‐Raz,et al. Retroperitoneal fibrosis: case series of five patients and review of the literature. , 2016, Revista brasileira de reumatologia.
[4] R. Sehgal,et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis , 2016, Clinical Rheumatology.
[5] A. Seremak-Mrozikiewicz,et al. [Retroperitoneal fibrosis--case report and literature review]. , 2015, Ginekologia polska.
[6] Chang-Keun Lee,et al. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis , 2015, Modern rheumatology.
[7] A. Vaglio,et al. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. , 2015, La Revue de medecine interne.
[8] S. Ferretti,et al. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis , 2013, Annals of the rheumatic diseases.
[9] N. Sainani,et al. Rethinking Ormond’s Disease , 2013, Medicine.
[10] C. Alberti. Revisiting the retroperitoneal fibroses: are there any significant news about their aetiopathogenesis and diagnostic approaches? , 2012, European review for medical and pharmacological sciences.
[11] J. Sass,et al. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis , 2011, Annals of the rheumatic diseases.
[12] S. Achenbach,et al. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. , 2011, Mayo Clinic proceedings.
[13] O. Matsui,et al. Retroperitoneal Fibrosis: A Clinicopathologic Study With Respect to Immunoglobulin G4 , 2009, The American journal of surgical pathology.
[14] K. Farrington,et al. Successful Use of Steroids and Ureteric Stents in 24 Patients with Idiopathic Retroperitoneal Fibrosis: A Retrospective Study , 2008, Nephron Clinical Practice.
[15] S. Ferretti,et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. , 2007, Kidney international.
[16] T. Hendriksz,et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] C. Ponticelli,et al. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] P. Bassi,et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. , 2004, The American journal of medicine.
[19] K. Hanash,et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. , 2002, The Journal of urology.
[20] M. Piegsa,et al. [Retroperitoneal fibrosis]. , 1993, Deutsche medizinische Wochenschrift.